Past Events
Past Events|04 Nov 2025
Co-organised with Lilly Ventures, this session explored how the firm is shaping the future of healthcare innovation through long-term partnerships and strategic investments. We heard from panellists Brad Robling (Vice President, Lilly Ventures and Catalyze 360 Transactions) and Jim Mackrell (Vice President, Venture Science, Lilly Ventures and C360 Transactions), who shared their perspectives on emerging trends, their investment focus, and how we can position our portfolios and startups for long-term impact.
Past Events|10 Nov 2025
ClavystBio brought together our portfolio companies for an exclusive roundtable with Steve Krognes, who shared his career journey from consulting and banking to serving as CFO at Genentech and Denali Therapeutics. The roundtable was facilitated by ClavystBio CFO Ong Kang Lin.
Past Events|22 Jul 2025
Co-organised with Duke-NUS Medical School, this session brings together scientific founders, operators, and commercialization leaders to share practical insights on translating academic research into impactful ventures across therapeutics, diagnostics, and MedTech. Panelists include Dr. Rainny Xie (LIVE Ventures, Duke-NUS), Dr. Wang Xiaomeng (Duke-NUS, A*STAR), and Koon Kiat Teu (Allay Therapeutics).
Past Events|21 Nov 2024
Co-organized with Enterprise Singapore, Droia’s Managing Partner Luc Dochez and leading pharma and biotech executive Andreas Wallnoefer provide invaluable insights into navigating successful biotech deal negotiations and partnerships.
Past Events|19 Nov 2024
Our inaugural Portfolio Day brought together our Board, portfolio companies, and partners for two days of networking and candid discussions. Focused on venture building within the life sciences ecosystem across Asia and globally, the event served as a unique platform for the ClavystBio family to share insights and foster the growth of global life science companies.
Past Events|04 Nov 2024
What does it take to truly connect with a big pharma? We unpacked this during a valuable discussion with MSD’s Discovery Leads Marc Levesque (Immunology), David Weinstock (Oncology), Erin Whalen (Cardiometabolic Research) and Director of BD and Licensing Koji Yashiro.
Past Events|09 Sep 2024
Co-hosted with National Health Innovation Centre (NHIC), this discussion explored the key ingredients for building a successful medtech venture with two key figures behind the growth of Allay Therapeutics: Lightstone Ventures' Mike Carusi and Allay's Koon Kiat Teu.
Past Events|17 Apr 2024
Dr. Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals joined us an inspiring ClavystBio Conversations session, bringing together women across our community.
Past Events|15 Apr 2024
Co-organized with Nucleate Singapore and CoVBio, we welcomed Jaap Goudsmit, a driving force behind Crucell's remarkable transformation from university spin-off into the Netherlands' leading biotech company. He shared invaluable wisdom with young innovators and entrepreneurs in our startup ecosystem.
Past Events|07 Mar 2024
We hosted Amy Schulman, Managing Partner, Polaris Partners and Luc Dochez, Managing Partner, Droia Ventures for an open exchange with innovators across our life sciences ecosystem. Focusing on biotech venture building, they shared insights from their extensive experience navigating diverse market conditions over the years.
Past Events|12 Dec 2023
It was a pleasure to host the Yabuli China Entrepreneurs Forum – China's premier thought leadership platform for business leaders – at Node 1 for a dynamic exchange of ideas and learnings on life sciences innovation and startup ecosystem growth.
Past Events|31 Oct 2023
Co-organized with NSG Ventures, we launched our ClavystBio Conversations series with serial entrepreneur and expert in synthetic biology Tim Lu.
Past Events|04 Oct 2023
We were honored to have Singapore Deputy Prime Minister Mr Heng Swee Keat officially launch ClavystBio and open Node, celebrating our dedication to venture building, life sciences innovation, and ecosystem growth. Even highlights included a keynote by Temasek CEO Dilhan Pillay and an expert panel led by ClavystBio Chairman Fidah Alsagoff, featuring with Professor Robert Langer, Highlander Health Co-founder Dr. Amy Abernethy, and Polaris Partners Founding Partner Terry McGuire.